Adaptimmune Therapeutics PLC (ADAPY) Research & Development (2015 - 2025)
Adaptimmune Therapeutics (ADAPY) recorded Research & Development of $22.98 million in Q2 2025, down 43.2% from $40.45 million a year earlier and down 20.4% from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Research & Development (2015 - 2025) Analysis & Trends
On a TTM basis, Adaptimmune Therapeutics' Research & Development came in at $125.24 million as of Jun 30, 2025, down 14.6% year-over-year; for FY2024, it came in at $149.06 million, up 17.8% from FY2023.
- Annual Research & Development has a five-year compound annual growth rate of 8.9% (FY2019 to FY2024).
- Across earlier years, Research & Development came in at $126.51 million in FY2023 (-1.0%), $127.73 million in FY2022 (+15.0%), $111.09 million in FY2021 (+21.3%) and $91.57 million in FY2020 (-6.1%).
- The Q2 2025 figure is the lowest quarterly Research & Development since Q2 2020.
- On a year-over-year basis, Research & Development rose in five of the last eight quarters, with growth averaging 9.8%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 50.0% in Q1 2022, against a decline of 43.2% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.86 million (Q1 2025), $39.1 million (Q4 2024) and $34.3 million (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 22.98 Mn |
| Mar 31, 2025 | 28.86 Mn |
| Dec 31, 2024 | 39.10 Mn |
| Sep 30, 2024 | 34.30 Mn |
| Jun 30, 2024 | 40.45 Mn |
| Mar 31, 2024 | 35.21 Mn |
| Dec 31, 2023 | 33.21 Mn |
| Sep 30, 2023 | 37.79 Mn |
| Jun 30, 2023 | 29.97 Mn |
| Mar 31, 2023 | 25.55 Mn |
| Dec 31, 2022 | 23.05 Mn |
| Sep 30, 2022 | 33.18 Mn |
| Jun 30, 2022 | 34.74 Mn |
| Mar 31, 2022 | 36.75 Mn |
| Dec 31, 2021 | 29.51 Mn |
| Sep 30, 2021 | 28.21 Mn |
| Jun 30, 2021 | 28.87 Mn |
| Mar 31, 2021 | 24.51 Mn |
| Dec 31, 2020 | 25.78 Mn |
| Sep 30, 2020 | 24.07 Mn |
API Access
Adaptimmune Therapeutics PLC Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();